171 related articles for article (PubMed ID: 21169411)
1. FUS/TLS is a novel mediator of androgen-dependent cell-cycle progression and prostate cancer growth.
Brooke GN; Culley RL; Dart DA; Mann DJ; Gaughan L; McCracken SR; Robson CN; Spencer-Dene B; Gamble SC; Powell SM; Wait R; Waxman J; Walker MM; Bevan CL
Cancer Res; 2011 Feb; 71(3):914-24. PubMed ID: 21169411
[TBL] [Abstract][Full Text] [Related]
2. FUS/TLS is a co-activator of androgen receptor in prostate cancer cells.
Haile S; Lal A; Myung JK; Sadar MD
PLoS One; 2011; 6(9):e24197. PubMed ID: 21909421
[TBL] [Abstract][Full Text] [Related]
3. MiR-133a-5p inhibits androgen receptor (AR)-induced proliferation in prostate cancer cells via targeting FUsed in Sarcoma (FUS) and AR.
Zheng L; Kang Y; Zhang L; Zou W
Cancer Biol Ther; 2020; 21(1):34-42. PubMed ID: 31736422
[TBL] [Abstract][Full Text] [Related]
4. Structure and function of FUS gene in prostate cancer.
Ghanbarpanah E; Kohanpour MA; Hosseini-Beheshti F; Yari L; Keshvari M
Bratisl Lek Listy; 2018; 119(10):660-663. PubMed ID: 30345776
[TBL] [Abstract][Full Text] [Related]
5. Role of androgen receptor in the progression of human prostate tumor cells to androgen independence and insensitivity.
Kokontis JM; Hsu S; Chuu CP; Dang M; Fukuchi J; Hiipakka RA; Liao S
Prostate; 2005 Dec; 65(4):287-98. PubMed ID: 16015608
[TBL] [Abstract][Full Text] [Related]
6. The F-box protein SKP2 mediates androgen control of p27 stability in LNCaP human prostate cancer cells.
Lu L; Schulz H; Wolf DA
BMC Cell Biol; 2002 Aug; 3():22. PubMed ID: 12188931
[TBL] [Abstract][Full Text] [Related]
7. Evolution of the androgen receptor pathway during progression of prostate cancer.
Hendriksen PJ; Dits NF; Kokame K; Veldhoven A; van Weerden WM; Bangma CH; Trapman J; Jenster G
Cancer Res; 2006 May; 66(10):5012-20. PubMed ID: 16707422
[TBL] [Abstract][Full Text] [Related]
8. Prostate cancer cells tolerate a narrow range of androgen receptor expression and activity.
Tararova ND; Narizhneva N; Krivokrisenko V; Gudkov AV; Gurova KV
Prostate; 2007 Dec; 67(16):1801-15. PubMed ID: 17935158
[TBL] [Abstract][Full Text] [Related]
9. ERRgamma suppresses cell proliferation and tumor growth of androgen-sensitive and androgen-insensitive prostate cancer cells and its implication as a therapeutic target for prostate cancer.
Yu S; Wang X; Ng CF; Chen S; Chan FL
Cancer Res; 2007 May; 67(10):4904-14. PubMed ID: 17510420
[TBL] [Abstract][Full Text] [Related]
10. A novel androgen receptor splice variant is up-regulated during prostate cancer progression and promotes androgen depletion-resistant growth.
Guo Z; Yang X; Sun F; Jiang R; Linn DE; Chen H; Chen H; Kong X; Melamed J; Tepper CG; Kung HJ; Brodie AM; Edwards J; Qiu Y
Cancer Res; 2009 Mar; 69(6):2305-13. PubMed ID: 19244107
[TBL] [Abstract][Full Text] [Related]
11. Nrdp1-mediated regulation of ErbB3 expression by the androgen receptor in androgen-dependent but not castrate-resistant prostate cancer cells.
Chen L; Siddiqui S; Bose S; Mooso B; Asuncion A; Bedolla RG; Vinall R; Tepper CG; Gandour-Edwards R; Shi X; Lu XH; Siddiqui J; Chinnaiyan AM; Mehra R; Devere White RW; Carraway KL; Ghosh PM
Cancer Res; 2010 Jul; 70(14):5994-6003. PubMed ID: 20587519
[TBL] [Abstract][Full Text] [Related]
12. Androgen regulation of micro-RNAs in prostate cancer.
Waltering KK; Porkka KP; Jalava SE; Urbanucci A; Kohonen PJ; Latonen LM; Kallioniemi OP; Jenster G; Visakorpi T
Prostate; 2011 May; 71(6):604-14. PubMed ID: 20945501
[TBL] [Abstract][Full Text] [Related]
13. Androgen-dependent regulation of Her-2/neu in prostate cancer cells.
Berger R; Lin DI; Nieto M; Sicinska E; Garraway LA; Adams H; Signoretti S; Hahn WC; Loda M
Cancer Res; 2006 Jun; 66(11):5723-8. PubMed ID: 16740710
[TBL] [Abstract][Full Text] [Related]
14. Genome-wide impact of androgen receptor trapped clone-27 loss on androgen-regulated transcription in prostate cancer cells.
Nwachukwu JC; Mita P; Ruoff R; Ha S; Wang Q; Huang SJ; Taneja SS; Brown M; Gerald WL; Garabedian MJ; Logan SK
Cancer Res; 2009 Apr; 69(7):3140-7. PubMed ID: 19318562
[TBL] [Abstract][Full Text] [Related]
15. Down-regulation of androgen receptor by 3,3'-diindolylmethane contributes to inhibition of cell proliferation and induction of apoptosis in both hormone-sensitive LNCaP and insensitive C4-2B prostate cancer cells.
Bhuiyan MM; Li Y; Banerjee S; Ahmed F; Wang Z; Ali S; Sarkar FH
Cancer Res; 2006 Oct; 66(20):10064-72. PubMed ID: 17047070
[TBL] [Abstract][Full Text] [Related]
16. Differential requirements for ras and the retinoblastoma tumor suppressor protein in the androgen dependence of prostatic adenocarcinoma cells.
Fribourg AF; Knudsen KE; Strobeck MW; Lindhorst CM; Knudsen ES
Cell Growth Differ; 2000 Jul; 11(7):361-72. PubMed ID: 10939590
[TBL] [Abstract][Full Text] [Related]
17. Sodium butyrate regulates androgen receptor expression and cell cycle arrest in human prostate cancer cells.
Kim J; Park H; Im JY; Choi WS; Kim HS
Anticancer Res; 2007; 27(5A):3285-92. PubMed ID: 17970072
[TBL] [Abstract][Full Text] [Related]
18. The tumor suppressor ING1b is a novel corepressor for the androgen receptor and induces cellular senescence in prostate cancer cells.
Esmaeili M; Jennek S; Ludwig S; Klitzsch A; Kraft F; Melle C; Baniahmad A
J Mol Cell Biol; 2016 Jun; 8(3):207-20. PubMed ID: 26993046
[TBL] [Abstract][Full Text] [Related]
19. Capsaicin, a component of red peppers, inhibits the growth of androgen-independent, p53 mutant prostate cancer cells.
Mori A; Lehmann S; O'Kelly J; Kumagai T; Desmond JC; Pervan M; McBride WH; Kizaki M; Koeffler HP
Cancer Res; 2006 Mar; 66(6):3222-9. PubMed ID: 16540674
[TBL] [Abstract][Full Text] [Related]
20. Amyloid precursor protein is a primary androgen target gene that promotes prostate cancer growth.
Takayama K; Tsutsumi S; Suzuki T; Horie-Inoue K; Ikeda K; Kaneshiro K; Fujimura T; Kumagai J; Urano T; Sakaki Y; Shirahige K; Sasano H; Takahashi S; Kitamura T; Ouchi Y; Aburatani H; Inoue S
Cancer Res; 2009 Jan; 69(1):137-42. PubMed ID: 19117996
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
